BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 4916807)

  • 21. A controlled clinical trial of trifluperidol on a group of chronic schizophrenic patients.
    Menon MS; Ramachandran V
    Curr Ther Res Clin Exp; 1972 Jan; 14(1):17-21. PubMed ID: 4621559
    [No Abstract]   [Full Text] [Related]  

  • 22. A comparison of two butyrophenones with trifluoperazine.
    Marjerrison G; Hrychuk W; Varsanyi EI
    Can Psychiatr Assoc J; 1966 Feb; 11(1):26-30. PubMed ID: 5322990
    [No Abstract]   [Full Text] [Related]  

  • 23. [Therapeutic results obtained with triperidol in a group of chronic schizophrenics].
    Motta E; Spadaro P
    Riv Sper Freniatr Med Leg Alien Ment; 1967 Jun; 91(3):802-17. PubMed ID: 5614833
    [No Abstract]   [Full Text] [Related]  

  • 24. An early clinical trial of lenperone (AHR 2277), a butyrophenone, in chronic schizophrenia.
    Simpson GM; Varga V
    Curr Ther Res Clin Exp; 1974 May; 16(5):477-82. PubMed ID: 4209063
    [No Abstract]   [Full Text] [Related]  

  • 25. Electroencephalographic effects of trifluperidol.
    Itil T; Fink M
    Dis Nerv Syst; 1969 Aug; 30(8):524-30. PubMed ID: 5809787
    [No Abstract]   [Full Text] [Related]  

  • 26. [Therapeutic effect of triperidol].
    Cwynar S; Pionkowski J; Tomczak W; Tyszka E
    Psychiatr Pol; 1968; 2(6):627-32. PubMed ID: 5730286
    [No Abstract]   [Full Text] [Related]  

  • 27. A comparison of pimozide with perphenazine in the treatment of acute schizophrenic psychoses.
    Svestka J; Náhunek K
    Act Nerv Super (Praha); 1972; 14(2):93-4. PubMed ID: 4557145
    [No Abstract]   [Full Text] [Related]  

  • 28. [Treatment of schizophrenia with imiclopazine, pimozide, imagotan and trifluorperidol. Comparative study].
    Nurowska K; Welbel L
    Psychiatr Pol; 1973; 7(1):57-63. PubMed ID: 4146043
    [No Abstract]   [Full Text] [Related]  

  • 29. [Clinical evaluation of a butyrophenone derivative, methylperidol, in 40 cases of schizophrenia and other psychoses].
    Vinci M
    Osp Psichiatr; 1971; 39(2):399-407. PubMed ID: 4948707
    [No Abstract]   [Full Text] [Related]  

  • 30. Assessment of antipsychotic activity of a butyrophenone analogue, lenperone (AHR 2277).
    Sathanathan GL; Angrist BM; Phillips N; Gershon S
    Curr Ther Res Clin Exp; 1974 Aug; 16(8):844-7. PubMed ID: 4217252
    [No Abstract]   [Full Text] [Related]  

  • 31. Trifluperidol and trifluoperazine in acute schizophrenic patients.
    Sugerman AA; Williams BH
    J New Drugs; 1965; 5(5):318-26. PubMed ID: 5329635
    [No Abstract]   [Full Text] [Related]  

  • 32. Pilot clinical study with trifluperidol (Trisedyl) therapy in psychotic patients.
    Dolezalová V; Faltus F; Soucek K
    Act Nerv Super (Praha); 1974 Aug; 16(3):171. PubMed ID: 4609154
    [No Abstract]   [Full Text] [Related]  

  • 33. [Central and peripheral secondary effects of some butyrophenones].
    Salvini L; Frosali L; Gigli M
    Minerva Anestesiol; 1969 Apr; 35(4):334-44. PubMed ID: 5789993
    [No Abstract]   [Full Text] [Related]  

  • 34. Effects of two butyrophenone compounds on acute schizophrenic patients: speculation on the neurophysiologic sites of action.
    Gallant DM; Bishop M; Guerrero-Figueroa R
    Int J Neuropsychiatry; 1967 Aug; 3():Suppl 1:53-60. PubMed ID: 4860981
    [No Abstract]   [Full Text] [Related]  

  • 35. Further observations on trifluperidol: a butyrophenone derivative.
    Gallant DM; Bishop MP; Nesselhof WM; Sprehe DJ
    Psychopharmacologia; 1965 Jan; 7(1):37-43. PubMed ID: 5318922
    [No Abstract]   [Full Text] [Related]  

  • 36. A pilot study of AL-449 in chronic schizophrenic patients.
    Sugerman AA
    Curr Ther Res Clin Exp; 1968 Oct; 10(10):533-6. PubMed ID: 4971469
    [No Abstract]   [Full Text] [Related]  

  • 37. [Palatoschisis induced by trifluperidol in mice].
    Vichi F; Pierleoni P; Orlando S; Tollaro I
    Sperimentale; 1968; 118(4):245-51. PubMed ID: 5740872
    [No Abstract]   [Full Text] [Related]  

  • 38. [A year's use of R2498 with chronic ambulatory schizophrenic patients].
    Madalena JC
    Hospital (Rio J); 1965 Aug; 68(2):279-84. PubMed ID: 5295121
    [No Abstract]   [Full Text] [Related]  

  • 39. Further studies of the butyrophenone, CI-601, in chronic schizophrenic patients.
    Edwards JG; Simpson GM
    Curr Ther Res Clin Exp; 1968 Oct; 10(10):520-8. PubMed ID: 4971467
    [No Abstract]   [Full Text] [Related]  

  • 40. Lenperone: a controlled evaluation in chronic schizophrenic patients.
    Mielke DH; Gallant DM; Kessler C; Roniger JJ
    Curr Ther Res Clin Exp; 1975 Nov; 18(5):636-40. PubMed ID: 812640
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.